Pet Treats Market worth $58.71 billion by 2031- Exclusive Report by MarketsandMarkets™

MarketsandMarkets projects the global pet treats market will rise from $38.40B in 2026 to $58.71B by 2031, implying an 8.9% CAGR. Growth is attributed to pet humanization, higher spending on premium/functional treats (e.g., dental and immune support), and faster adoption of e-commerce (largest ~37% share in 2026). Asia Pacific is forecast to lead growth with 11.8% CAGR, while freeze-dried and immune-supporting products are highlighted as the fastest-growing segments.

Analysis

This is a category-growth story, not an immediate earnings shock. The investable angle is mix shift: premium, functional, and e-commerce-distributed treats should take share inside pet spend, which favors brands with SKU innovation, pricing power, and direct data on repeat purchases. That is more constructive for FRPT and CHWY than for broad staples, because the upside is in premium mix and subscription frequency rather than a one-time unit spike.

The hidden loser is legacy, mass-market treat assortment and any business reliant on in-store planograms. Online growth reduces retailer control over shelf space and increases price transparency, which tends to compress promo-driven brands first; it also raises fulfillment intensity for CHWY, so gross profit dollars can grow faster than EBITDA unless basket size and auto-ship stay strong. Input exposure matters too: meat-based and freeze-dried formats are the right product mix, but they are more sensitive to animal protein inflation and processing capacity, so margin expansion could lag revenue growth.

Contrarianly, the market may be overestimating how much of a TAM forecast converts into public-equity alpha. Treats are still discretionary, and the fastest-growing subsegments carry claim-validation risk if dental/immune marketing gets challenged or if consumer trade-down shows up in POS data. The thesis would be falsified by slowing online sell-through, gross margin compression from promoing, or commentary that pet owners are shifting back to cheaper reward-based treats rather than premium functional products.

Key Decisions for Investors

• Watch FRPT for a 5-8% pullback entry over the next 1-3 months; best pure-play exposure to premium/freeze-dried mix, but require confirmation that gross margin is not being eaten by protein inflation before sizing up.
• Run a relative-value long CHWY / short SJM pair for the next 1-2 quarters if online pet penetration continues to outgrow store channels; CHWY captures channel share, while SJM has more legacy-brand exposure and less operating leverage to e-commerce mix.
• Do not chase GIS or CL on this print alone; the treat-category tailwind is too small versus their consolidated earnings base unless upcoming quarter commentary shows explicit pet-segment acceleration.
• Set an alert on CHWY EBITDA margin and fulfillment expense in the next earnings cycle; if shipping costs rise faster than AOV, the e-commerce growth story becomes revenue-positive but not stock-positive.